Challenges and applications of artificial intelligence in infectious diseases and antimicrobial resistance

By improving quick detection and drug development, artificial intelligence (AI) has revolutionized the control of infectious diseases. AI-driven techniques like machine learning and deep learning help with medication discovery, resistance prediction, and pathogen detection, whereas traditional testing delays diagnosis. These instruments enhance antibiotic stewardship and detect potent substances including small molecules and antimicrobial peptides. This review examines AI applications in drug development, therapy, and diagnostics, highlighting both their advantages and shortcomings.